To include your compound in the COVID-19 Resource Center, submit it here.

Human Genome Sciences, GlaxoSmithKline sales and marketing update

In a presentation, Human Genome Sciences said it and partner GlaxoSmithKline launched Benlysta belimumab in the U.S. to treat patients with active, autoantibody-positive systemic lupus

Read the full 254 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE